Literature DB >> 7934492

Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features.

J Chelsom1, A Halstensen, T Haga, E A Høiby.   

Abstract

During November, 1992, to May, 1994, 13 patients were treated at Haukeland University Hospital, Norway, for necrotising fasciitis due to group A beta-haemolytic streptococci. 3 patients died, 1 before admission. Mucoid group A streptococci were isolated from affected tissue (12 patients) and/or blood (5). Strains from 11 patients were serotype M-1 (5 patients), M-3 (2), M-6 (2), M-28 (1), and M-untypable (T-1, opacity factor negative) (1). For the 12 patients admitted alive, the following preoperative events were recorded: 8 had clinical signs of shock with systolic blood pressure of 90 mm Hg or less, 8 had impaired renal function, and 7 had biochemical markers of disseminated intravascular coagulation. At least 6 patients fulfilled the criteria for streptococcal toxic shock syndrome. Preoperative C-reactive protein was substantially raised ( > 200 mg/L) in 10 patients. The 12 patients were given high doses of antibiotics and were operated on with aggressive debridement of necrotic skin and fascia, 7 of them within 24 h of admission. The increasing incidence of necrotising fasciitis in western Norway reflects the resurgence of invasive group A streptococcal infections documented in Scandinavia since 1987. The high case-fatality rate can be reduced by early diagnosis and aggressive surgery combined with adequate antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934492     DOI: 10.1016/s0140-6736(94)90629-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  49 in total

1.  Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong.

Authors:  P L Ho; D R Johnson; A W Y Yue; D N C Tsang; T L Que; B Beall; E L Kaplan
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Survey of phenotypic and genetic features of streptococcus pyogenes strains isolated in Northwest Italy.

Authors:  Simona Bianco; Tiziano Allice; Mario Zucca; Dianella Savoia
Journal:  Curr Microbiol       Date:  2005-12-26       Impact factor: 2.188

3.  Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen gene detection.

Authors:  Kenneth L Muldrew; Jean F Simpson; Charles W Stratton; Yi-Wei Tang
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

4.  Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002).

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Bertha Kress; Karen Grimsrud
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 5.  Necrotising fasciitis: a new management algorithm based on clinical classification.

Authors:  Paul S Carter; Paul E Banwell
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

6.  Necrotising fasciitis as a complication of steroid injection.

Authors:  R Birkinshaw; J O'Donnell; I Sammy
Journal:  J Accid Emerg Med       Date:  1997-01

Review 7.  Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.

Authors:  Christine S Cocanour; Phillip Chang; Jared M Huston; Charles A Adams; Jose J Diaz; Charles B Wessel; Bonnie A Falcione; Graciela M Bauza; Raquel A Forsythe; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2017-04-04       Impact factor: 2.150

8.  Necrotising fasciitis.

Authors:  Ulrike Dapunt; Alexander Klingmann; Gerhard Schmidmaier; Arash Moghaddam
Journal:  BMJ Case Rep       Date:  2013-12-10

9.  Subacute necrotizing fasciitis caused by gas-producing Staphylococcus aureus.

Authors:  W R Saliba; L H Goldstein; R Raz; R Mader; R Colodner; M S Elias
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-25       Impact factor: 3.267

10.  Risk for severe group A streptococcal disease among patients' household contacts.

Authors:  Katherine A Robinson; Gretchen Rothrock; Quyen Phan; Brenda Sayler; Karen Stefonek; Chris Van Beneden; Orin S Levine
Journal:  Emerg Infect Dis       Date:  2003-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.